JPRN-UMIN000004246招募中未知
The Step-Up-Trial by biphasic insulin analogues - High-Mix Study
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Type 1 diabetic patients 2. Patients who are pregnant or likely to become pregnant 3. Patients with severe complications 4. Patients having difficulty with the drug compliance 5. Other patients determined to be inappropriate for participating in this study by the physician
研究者
相似试验
招募中
不适用
A Step therapy by a premixed insulin therapies in poor control with type 2 diabetestype 2 diabetesJPRN-UMIN000008884yokohama city university school of medicine endcrinology and metabolism40
已完成
不适用
Jikei-Evaluation of basal insulin analogue on (nocturnal) glycemic variability with continuous glucose monitoring -existing basal insulin analogue versus Tresiba ; insulin degludec - a new basal insulin analogue, in basal-bolus treatment in type 2 diabetesType 2 diabetesJPRN-UMIN000013818The Jikei University School of Medicine100
进行中（未招募）
不适用
A trial comparing sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensificatioDiabetes Mellitus, Type 2EUCTR2013-002878-47-HUovo Nordisk A/S64
进行中（未招募）
不适用
A trial comparing sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensificatioDiabetes Mellitus, Type 2MedDRA version: 16.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2013-002878-47-ESovo Nordisk A/S64
进行中（未招募）
不适用
A trial comparing sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensificatioDiabetes Mellitus, Type 2EUCTR2013-002878-47-SKovo Nordisk A/S64